Myelodysplastic-Myeloproliferative Diseases
Conditions
Keywords
MDS, Myelodisplastic Syndrome
Brief summary
Epidemiological data collection of adult patients affected by myelodysplastic syndrome (MDS) newly diagnosed.
Detailed description
Development of an Italian regional registries MDS network using the same electronic case report form for data storage, with the following broad aims: * Ability to aggregate and process anonymous epidemiological data collected by individual regional registers; * Ability to aggregate the available data with those of other international registries existing.
Interventions
None listed
Sponsors
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 106 Years
Healthy volunteers
No
Inclusion criteria
* New diagnosis of MDS
Exclusion criteria
* Patient who refuse the signature of informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of MDS diagnosis | 6 years | Number of new cases every 100.000 person/year |
| Overall Response rate | 6 years | Proportion of CR or PR after each line of treatment in term of erythroid, platelet and granulocyte response |
| Prevalence of MDS | 6 years | Number of cases every 100.000 person |
| Overall survival | 6 years | Time between MDS diagnosis and death due to any causes |
| Progression free survival | 6 years | Time between MDS diagnosis and relapse/ progression or death due to any causes |
| Progression to AML | 6 years | Time between MDS diagnosis and Progression to AML or death due to any causes |
Countries
Italy
Contacts
CONTACTValeria Santini, Prof.
CONTACTSegreteria FISM
Outcome results
None listed